At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.
Abzena is an England-based contract research organization that offers services such as antibody discovery and drug conjugate development for the biopharmaceutical sector.